Tetra Bio-Pharma Inc.
TBP
Rangering i aksjer
#35435
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aksjekurs
$0.01851783
Sist synkronisert: 2023-05-23
Markedsverdi
$3.71M
Endring (1 dag)
-0.04%
Endring (1 år)
1,443.15%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
Historikk for aksjesplitt for Tetra Bio-Pharma Inc. (TBP)
Aksjen Tetra Bio-Pharma Inc. (symbol: TBP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én TBP-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 TBP-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én TBP-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 TBP-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
